Tarsus Pharmaceuticals Announces Oversubscribed $125.0 Million Private Placement Equity Financing

Summary

Tarsus Pharmaceuticals announced an oversubscribed $125.0 million PIPE financing with qualified institutional buyers and accredited investors. The financing is expected to generate gross proceeds of approximately $125.0 million before placement agent fees and other expenses.